Who invested in Biohaven Pharmaceutical

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$280Mraised across 2 rounds since 2016, from 2 sources

$80MRound$200MRound

Latest round: Round, $200MNov 2025
Step-upi: 2.5×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2018202020222024

$80MRound$200MRound

First round: Round, $80M
Biggest round: $200M
Between rounds: 9 years

The rounds

Nov 2025
Round$200M3 new1 returning
Source recorded
Nov 2016
Round$80M1 new
- Venrock
Reported by FinSMEsSEC filing: $40M sold, first sale Oct 2016

Founders and team

From Biohaven Pharmaceutical's own website: 73 on the team.

Beth MorrisVice President, Clinical Operations
Caroline Dircks Ph.D.Senior Vice President, Corporate & Portfolio Operations
Francine HealyVice President, Global Regulatory Documentation
Javier GonzalezVice President, CMC Technical Operations
Jim MatherVice President, Clinical Operations
Kimberly GentileSenior Vice President, Clinical Operations
Lopa BakraniaVice President, CMC‑Regulatory Affairs
Mary SullivanVice President, Regulatory Affairs
Matthew DeLawderVice President, Accounting Operations
Michele PotashmanVice President, Clinical Outcomes Assessments & Health Economics
Stephanie PfisterVice President, Clinical Operations
John McGillChief Technology Officer
Matthew ButenChief Financial Officer
Alex GreifSenior Director, Lab Operations & Facilities
Alexandra PeckLab Operations Specialist
Ana EstrellaSenior Research Scientist
Andrea MondelloSenior Director, Clinical Quality Compliance
Anita ElginDirector, Clinical Data Management & Clinical Operations

And 55 more on the team.

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2016Round2025

Venrock

RA Capital Management

Connecticut Innovations

Vivo Capital

Everyone who backed them

VenrockVC firm2rounds

RA Capital ManagementPrivate equity1round

Connecticut InnovationsGovernment1round

Vivo CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Biohaven Pharmaceutical as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.